Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism

Thromb Res. 2014 May:133 Suppl 2:S29-34. doi: 10.1016/S0049-3848(14)50005-9.

Abstract

Background: The influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism (VTE) has not been thoroughly studied.

Methods: We used the RIETE Registry data to compare the 3-month mortality rate in cancer patients with VTE, with patients categorized according to the presence of recent immobilization, surgery or neither. The major outcomes were fatal pulmonary embolism (PE) and fatal bleeding within the first 3 months.

Results: Of 6,746 patients with active cancer and acute VTE, 1,224 (18%) had recent immobilization, 1,055 (16%) recent surgery, and 4,467 (66%) had neither. The all-cause mortality was 23.4% (95% CI: 22.4-24.5), and the PE-related mortality: 2.5% (95% CI: 2.1-2.9). Four in every ten patients dying of PE had recent immobilization (37%) or surgery (5.4%). Only 28% of patients with immobilization had received prophylaxis, as compared with 67% of the surgical. Fatal PE was more common in patients with recent immobilization (5.0%; 95% CI: 3.9-6.3) than in those with surgery (0.8%; 95% CI: 0.4-1.6) or neither (2.2%; 95% CI: 1.8-2.6). On multivariate analysis, patients with immobilization were at an increased risk for fatal PE (odds ratio: 1.8; 95% CI: 1.2-2.5).

Conclusions: One in every three cancer patients dying of PE had recent immobilization for ≥ 4 days. Many of these deaths could have been prevented with adequate thromboprophylaxis.

Keywords: Cancer; Death; Immobilization; Pulmonary embolism; Surgery; Venous thromboembolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Female
  • Hemorrhage / chemically induced
  • Hemorrhage / mortality
  • Humans
  • Immobilization / adverse effects*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasms / mortality*
  • Neoplasms / surgery*
  • Pulmonary Embolism / etiology
  • Pulmonary Embolism / mortality*
  • Pulmonary Embolism / prevention & control
  • Registries / statistics & numerical data
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / mortality*
  • Venous Thromboembolism / prevention & control

Substances

  • Anticoagulants